CN104083780A - Medical contrast agent containing unsaturated polymer - Google Patents

Medical contrast agent containing unsaturated polymer Download PDF

Info

Publication number
CN104083780A
CN104083780A CN201410314232.4A CN201410314232A CN104083780A CN 104083780 A CN104083780 A CN 104083780A CN 201410314232 A CN201410314232 A CN 201410314232A CN 104083780 A CN104083780 A CN 104083780A
Authority
CN
China
Prior art keywords
microsphere
layer
silicon dioxide
contrast agent
copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410314232.4A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU LONGHUA NEW SCIENCE & TECHNOLOGY Co Ltd
Original Assignee
CHENGDU LONGHUA NEW SCIENCE & TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU LONGHUA NEW SCIENCE & TECHNOLOGY Co Ltd filed Critical CHENGDU LONGHUA NEW SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201410314232.4A priority Critical patent/CN104083780A/en
Publication of CN104083780A publication Critical patent/CN104083780A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a medical contrast agent containing unsaturated polymer. A microsphere, namely the medical contrast agent is of a hollow inorganic/organic/inorganic three-layer structure, a cavity is formed in the center of the microsphere, and air is filled inside the cavity; the outer layer of the cavity is provided with alpha-Fe2O3 magnetic particles; the intermediate layer is a core/shell polymer nanomicrosphere which is obtained by copolymerizing a polybutadiene-polyacrylic acid random copolymer, polyacrylic acid and divinyl benzene by means of free radicals, and the copolymer is stable because a coordinate bond or ionic bond can be formed between the copolymer and the alpha-Fe2O3 magnetic particles on the inner layer through carboxyl and ferric salt on the inner surface; the outer layer is silicon dioxide, and is connected with the silicon hydroxyl on the surface of the silicon dioxide through carboxyl on the surface of the microsphere by generating a hydrogen-bond interaction with the silicon hydroxyl on the surface of the silicon dioxide. The medical contrast agent has the advantages that the copolymer microsphere belongs to nano-grade particles, targeted location of the contrast agent can be realized by means of the alpha-Fe2O3 magnetic particles on the inner layer, the silicon dioxide hollow microsphere has good biocompatibility and mechanical stability, and the inner cavity can generate a strong echo signal under a radiography mode.

Description

A kind of containing unsaturated high molecular medical contrast medium
Technical field
The present invention relates to a kind of medical treatment detection contrast agent, relate in particular to a kind of Nano microsphere with the multilamellar organic/inorganic composite construction of magnetic function, belong to medicine technology field.
Background technology
In recent years, molecular image technology is because it can provide important information to be paid close attention to widely (Campbell R. E., Chang C. J. for medical diagnosis on disease and the monitoring of biological tissue curr Opin Chem Biol, 2010,14 (1): 1-2.).In numerous imaging patterns, ultra sonic imaging is as a kind of AT biomedical imaging pattern, because it has imaging and diagnosis safety is timely, cheap, light and fast, utilization are extensive etc. that advantage has important researching value.Yet between different biological tissues, the difference of echo-signal usually can hinder the accuracy of diagnosis; in order to obtain better the accurate information of particular organization; people conventionally adopt (the R. D í az-L ó PBz that adds the method for ultra sonic imaging contrast agent to realize; Tsapisa N.; Libong D., et al. biomaterials, 2009,30 (8): 1462-1472.).
Conventionally contrast agent used is mainly microvesicle, and its shell is that the amphipathic small molecules such as saccharide, protein or polymer form, the inner C that fills 3f 8, SF 6deng gas, form vesicle (Ferrara K. W., Borden M. A., Zhang H. acc Chem Res, 2009,42 (7): 881-892.).These contrast agent can change or strengthen ultrasound echo signal and better surface or organizational information are provided.Yet due to laplace pressure, blood pressure, oxidative metabolism and hyperacoustic effect, these gas microbubbles are to inject blood just dissolved and break several seconds after, and particle diameter is difficult to control (Schutt E. G., Klein D. H., Mattrey R. M., et al. angew Chem Int Ed, 2003,42 (28): 3218-3235.).SiO 2 hollow microsphere has good biocompatibility and mechanical stability, and has larger cavity, under radiography pattern, can produce stronger echo-signal, can address the above problem.(Lin P. L., Eckersley R. J., the Elizabeth A. H. such as Hall adv Mater2009,21 (38-39): 3949-3952.) take PB ball as template, by polyene acid propyl hydrochlorate (PAH) change surface charge, having prepared particle diameter is the tiny balloon of 2.8 μ m, shell thickness is less than 30nm, and has studied its ultra sonic imaging effect under different mechanical index conditions.Linear ultrasonic imaging (B-model) result shows, this hollow SiO 2bead has very strong ultrasonic signal under water environment.Yet these class methods still have certain limitation, as hollow SiO 2the size of bead is too large, does not reach nanoscale structures, is difficult to for living imaging, and does not carry out modified with functional group and be difficult to further connect.Therefore, the contrast agent of clinical middle use at present can't be taken into account good biocompatibility, mechanical stability, Targeting Performance, nanostructured simultaneously, can be carried out the requirements such as modified with functional group.
Summary of the invention
The present invention is directed to above problem, provide a kind of containing unsaturated high molecular medical contrast medium, it is a kind of multilamellar organic/inorganic composite construction magnetic Nano microsphere, have hollow type inorganic/organic/inorganic three-layer composite structure:
What be positioned at microsphere center is cavity, the inner air of filling;
Intermediate layer is macromolecule layer, is the copolymer of polyacrylic acid and divinylbenzene;
Between cavity and intermediate layer, be -Fe 2o 3magnetic nano-particle, is deposited on macromolecule layer inner surface by coordinate bond or ionic bond;
Outer for there being mesoporous Nano particles of silicon dioxide, by hydrogen bond action, adsorb with macromolecule layer outside.
The technical solution adopted for the present invention to solve the technical problems is:
1) preparation of core/shell polymer microsphere double-layer nanometer microsphere
This microsphere is prepared based on a kind of core/shell polymer microsphere double-layer nanometer microsphere.First utilize butadiene and acrylic acid to carry out copolymerization and obtain dispersed nano microsphere, it is structure shown in following chemical formula:
The integer that wherein x is 5 ~ 50;
Y is 0 ~ 15 integer;
2) prepare the outer cross-linked structure of double-layer nanometer microsphere
Then by above-mentioned dispersed nano microsphere and polyacrylic acid, divinylbenzene, by Solution Free Radical copolymerization process, obtain microsphere layer structure, it is structure shown in following chemical formula:
The integer that wherein n is 0 ~ 50
3) by " certainly disperseing " polyreaction, prepare core/shell polymer microsphere double-layer nanometer microsphere
Utilize the surperficial carboxyl of double-layer nanometer microsphere to produce hydrogen bond action with the silicon hydroxyl of silica surface, make silicon dioxide form shell structurre in aggregate surface hydrolysis polycondensation.Its interaction chemical formula is as follows:
4) preparation of hollow macromolecule-silicon dioxide nanosphere
Utilize acetone to extract kernel and form hollow macromolecule-silicon dioxide nanosphere structure.In reaction system, add chloroform to dissolve, stirred for several hour, obtains SiO after utilizing chloroform to dissolve PB core 2tiny balloon, its form keep stable and structural integrity, there is good spherical structure.Preparation process schematic diagram is as shown in Figure of description 4;
5) preparation of magnetic macromolecular microsphere
Because Nano microsphere inside prepared in above-mentioned steps exists a large amount of carboxyls, at silica surface, there are a large amount of micropores simultaneously.Therefore, can utilize this micropore as passage, by Fe 3+add after reaction system, utilize microchannel to enter hollow ball inside, add PEG simultaneously, NaOH, regulates pH value, makes internal layer combination -Fe 2o 3magnetic particle.Nano microsphere internal layer macromolecule exists -Fe 2o 3surface has formed Fe-O-C key, and forms internal magnetization particle layer.
By above technical scheme, tool of the present invention has the following advantages: 1) containing unsaturated high molecular medical contrast medium, have good biocompatibility;
2) containing unsaturated high molecular medical contrast medium, there is volume little, there is nanoscale structures, can be by various human body barriers;
3) containing unsaturated high molecular medical contrast medium owing to containing superparamagnetism -Fe 2o 3, therefore there is Targeting Performance;
4) high containing unsaturated high molecular medical contrast medium Stability Analysis of Structures, mechanical stability.
This type of can overcome the problems such as traditional contrast agent poor stability, echo signal is weak, biocompatibility is poor containing unsaturated high molecular medical contrast medium.
Accompanying drawing explanation
Fig. 1 is this structural representation containing unsaturated high molecular medical contrast medium;
Fig. 2 is this particle diameter test pattern containing unsaturated high molecular medical contrast medium;
Fig. 3 is this AFM scintigram containing unsaturated high molecular medical contrast medium;
Fig. 4 is the preparation flow schematic diagram of hollow polymer microsphere.
The specific embodiment
For making enforcement object of the present invention, technical scheme and advantage more clear, below in conjunction with the drawings and specific embodiments of the present invention, the present invention is described in detail:
As shown in Figure 1, be the structural representation containing unsaturated high molecular medical contrast medium.This Nano microsphere has hollow type machine/organic/inorganic three-layer composite structure, has successively: outermost layer be Nano particles of silicon dioxide 1.; Intermediate layer be macromolecule layer 2.; Internal layer is -Fe 2o 3magnetic nano-particle 3.; Be positioned at microsphere center be cavity 4., the inner air of filling.Wherein Nano particles of silicon dioxide layer should have meso-hole structure in 1..
As macromolecule layer 2., silicon dioxide granule is adsorbed in outside 1. to polyacrylic acid-divinylbenzene crosslinking copolymerization macromolecule simultaneously, and internal layer combination -Fe 2o 3magnetic nano-particle is 3. as an embodiment preferably: utilize butadiene and polyacrylic acid to carry out copolymerization and obtain internal layer microsphere, then internal layer is carried out to copolymerization by polyacrylic acid and divinylbenzene, obtain double-deck solid nano polymer microspheres.Utilize the surperficial carboxyl of double-layer nanometer microsphere to produce hydrogen bond action with the silicon hydroxyl of silica surface, make silicon dioxide form shell structurre 1. in aggregate surface hydrolysis polycondensation.Meanwhile, utilize the meso-hole structure of Nano particles of silicon dioxide, with an organic solvent method (acetone) extracts kernel and forms hollow macromolecule-silicon dioxide double-layer nanometer micro-sphere structure.Finally, utilize microsphere inner surface carboxyl and iron salt can form coordinate bond or ionic bond, by adsorption and permeation, enter the Fe of hollow ball inside 2+and Fe 3+deng reactant, make internal layer combination -Fe 2o 3magnetic particle 3..
Figure 2 shows that and utilize the particle diameter test pattern of dynamic light scattering method to magnetic Nano microsphere, can find out, Nano microsphere particle diameter is less than 1 micron, and particle size distribution is narrower, proves that this Nano microsphere volume is little, good dispersion.
Figure 3 shows that the AFM scanogram containing unsaturated high molecular medical contrast medium.Proof macromolecule forms globular micelle structure homogeneous, and good dispersion is not reunited in aqueous solution.Be conducive to targeting location and the dispersion of contrast agent in body fluid.
Provide embodiment below so that the present invention is specifically described; but it is worthy of note that following examples are only used to further illustrate the present invention; can not be interpreted as limiting the scope of the invention, some nonessential improvement that the person skilled in the art in this field makes the present invention according to the invention described above content and adjustment still belong to protection scope of the present invention.
Embodiment 1:
1. the preparation of core/shell polymeric Nano microsphere
Step 1: single (PB-PAA) copolymer microsphere that disperses of method preparation that first adopts " certainly disperseing " polymerization.In tri-mouthfuls of round bottom reaction bulbs of 500mL, add butadiene and each 0.2mol of acrylic acid, AIBN(azo-bis-isobutyl cyanide) 0.98g, butyl acetate 280 mL; under nitrogen protection; 70 ℃ of reactions of constant temperature 12 hours, product is dried in 55 ℃ of baking ovens, obtains single dispersion (PB-PAA) copolymer microsphere.
Step 2: " certainly disperse " polyreaction to prepare core/shell polymer microsphere with seed.By (PB-PAA) copolymer microsphere 3.65g, acrylic acid and each 0.038mol of divinylbenzene, AIBN 0.09 g, butyl acetate 100 mL, normal hexane 35 mL; add in reaction bulb; under nitrogen protection, 75 ℃ of reactions of constant temperature 13 hours, obtain two-layer core/shell polymeric Nano microsphere.
2. silicon dioxide is assembled and is formed shell structurre at microsphere surface
Two-layer core/shell polymeric the Nano microsphere prepared in above-mentioned steps of take is template, by sol-gel process, at PAA surface in situ, generates thickness homogeneous and the regular SiO of pattern 2shell.Adopt St ber method (St ber W., Fink A., Bohn E. j Colloid Interface Sci, 1968,26 (1): 62-69.), adding 55mL ammonia is catalyst, utilize ethyl orthosilicate (TEOS) 16.5g, synthetic SiO after hydrolysis and polycondensation reaction 2.
With PAA surface PB core, as template, deposit SiO 2time, generally can generate the independent SiO about 35nm 2particle.Because PB checks SiO 2adsorptivity a little less than, if directly precipitate SiO with PB as masterplate 2, be difficult to obtain uniform SiO 2shell structurre.And after the surface and copolymerized PAA of PB core, because of the carboxyl on PAA chain or carboxylate radical can with hydrolyzate and the SiO of ethyl orthosilicate 2the hydroxyl of particle surface forms hydrogen bond, thus induction SiO 2nucleating growth, finally forms regular shell structurre.
3. hollow type polymer-SiO 2the preparation of Nano microsphere
Get the SiO preparing in 2.7g above-mentioned steps 2core/shell polymeric Nano microsphere adds 15mL chloroform to dissolve in reaction system, stirs 7 hours, obtains SiO after utilizing chloroform dissolving PB core 2tiny balloon, its form keep stable and structural integrity, there is good spherical structure.
4. the preparation of hollow type magnetic Nano microsphere contrast agent
The hollow polymer microsphere 1g, the FeCl that in tri-mouthfuls of round bottom reaction bulbs of 250mL, add gained in above-mentioned reactions steps 36H 2o 6g, deionized water 150mL, then add 5 mL PEG-400, under magnetic agitation, with dilute NaOH solution, the pH value of mixed solution is adjusted to 3.After reaction finishes, product is through centrifugalize, and by distilled water and washing with alcohol repeatedly, in 60 ℃ of vacuum tanks, dries.Above-mentioned microsphere is added in bag filter, with 1000 mL pure water dialysis, refresh the water periodically.Dialysis solution is with after membrane filtration, and lyophilization obtains hollow type magnetic Nano microsphere contrast agent.
Finally it should be noted that, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although the present invention is had been described in detail with reference to preferred embodiment, those of ordinary skill in the art should understand, can a minute technical scheme for invention be modified or be replaced on an equal basis, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of claim scope of the present invention.

Claims (5)

1. containing a unsaturated high molecular medical contrast medium, it is characterized in that having hollow type inorganic/organic/inorganic three-layer composite structure:
1) what be positioned at microsphere center is cavity, the inner air of filling;
2) intermediate layer is macromolecule layer, is the copolymer of polyacrylic acid and divinylbenzene;
3) between cavity and intermediate layer, be -Fe 2o 3magnetic nano-particle;
4) skin is Nano particles of silicon dioxide.
2. according to claim 1 a kind of containing unsaturated high molecular medical contrast medium, this material is prepared as follows:
1) prepare polybutadiene-acrylic acid random copolymerization list diffuse nuclei/shell polymeric Nano microsphere;
2) silicon dioxide is assembled at microsphere surface;
3) prepare hollow type polymer-SiO 2nano microsphere;
4) preparation of hollow type magnetic Nano microsphere contrast agent.
3. according to claim 1 and 2 a kind of containing unsaturated high molecular medical contrast medium, be further characterized in that above-mentioned steps 1) in formed core/shell polymeric Nano microsphere be double-decker, and be all to adopt polyacrylic acid as hydrophilic segment, it is characterized in that:
1) its internal layer is polybutadiene-acrylic acid random copolymer;
2) its skin is polyacrylic acid and divinyl benzene crosslinked polymer.
4. according to claim 1 and 2 a kind of containing unsaturated high molecular medical contrast medium, be further characterized in that: in outermost Nano particles of silicon dioxide, there is meso-hole structure.
5. according to claim 1 and 2 a kind of containing unsaturated high molecular medical contrast medium, be further characterized in that: macromolecule layer is the copolymer of polyacrylic acid and divinylbenzene, macromolecule has double-deck polyacrylic acid structure, utilizes divinylbenzene bridging between molecule.
CN201410314232.4A 2014-07-03 2014-07-03 Medical contrast agent containing unsaturated polymer Pending CN104083780A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410314232.4A CN104083780A (en) 2014-07-03 2014-07-03 Medical contrast agent containing unsaturated polymer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410314232.4A CN104083780A (en) 2014-07-03 2014-07-03 Medical contrast agent containing unsaturated polymer

Publications (1)

Publication Number Publication Date
CN104083780A true CN104083780A (en) 2014-10-08

Family

ID=51631602

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410314232.4A Pending CN104083780A (en) 2014-07-03 2014-07-03 Medical contrast agent containing unsaturated polymer

Country Status (1)

Country Link
CN (1) CN104083780A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013079363A1 (en) * 2011-11-30 2013-06-06 Evonik Degussa Gmbh Magnetic core-shell particles
CN104436226A (en) * 2013-09-16 2015-03-25 成都市绿科华通科技有限公司 Ultrasound diagnosis medical polymer material with targeting function

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013079363A1 (en) * 2011-11-30 2013-06-06 Evonik Degussa Gmbh Magnetic core-shell particles
CN104436226A (en) * 2013-09-16 2015-03-25 成都市绿科华通科技有限公司 Ultrasound diagnosis medical polymer material with targeting function

Similar Documents

Publication Publication Date Title
CN104338153A (en) Hollow type magnetic nanoparticle contrast agent.
CN104338152A (en) Medical targeting contrast agent microsphere
CN104436228A (en) Novel magnetic ferric oxide hollow microsphere contrast agent
CN104436226A (en) Ultrasound diagnosis medical polymer material with targeting function
CN104415370A (en) Polymer magnetic particle composite ultrasonic imaging microsphere
CN104415359A (en) Organic-inorganic composite hollow ultrasound imaging microsphere material
CN104436223A (en) Medical high-molecular polymer microspheres containing magnetic particles
CN104436236A (en) Novel biocompatible polymer magnetic contrast agent
CN104436230A (en) Medical polymer ultrasound imaging microspheres
CN104436241A (en) Medical ultrasound diagnosis nanometer microsphere contrast agent system
CN104436224A (en) Magnetic ferric oxide composite medical contrast agent
CN104436242A (en) Composite nanometer microsphere system for medical diagnosis
CN104436235A (en) Composite hollow microsphere ultrasound contrast agent
CN104083780A (en) Medical contrast agent containing unsaturated polymer
CN104436245A (en) Magnetic targeting medical diagnosis microsphere preparation method
CN104415361A (en) Composite hollow-type medical contrast medium system
CN104415377A (en) Polymer ultrasonic imaging contrast agent containing unsaturated bonds
CN104415356A (en) Medical polymer contrast agent microsphere containing polymethyl acrylate
CN104415375A (en) Polymer ultrasonic imaging microsphere containing magnetic particles
CN104415364A (en) Polyacrylonitrile-containing medical high-molecular contrast agent microballoon
CN104415374A (en) Preparation method of targeting polymer microsphere medical contrast agent
CN104415360A (en) Nano magnetic microspheric ultrasound imaging contrast medium
CN104415367A (en) Medical ultrasonic diagnosis contrast agent hollow composite microsphere system
CN104127891A (en) Method for preparing magnetic microsphere by using polybutadiene
CN104415358A (en) Composite type ultrasound imaging contrast agent preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141008